19 results
Goal-Directed Therapy - Evidence Summary of Major Clinical Trials

 - EGDT: NEJM 2001

 - ProCESS: NEJM
2014 - ARISE ... : NEJM 2014 ... - ProMlSe: NEJM ... 2015 Vivek Moitra ... Therapy #Trials #EBM
Major Clinical Trials and Evidence Summary for Transfusion Thresholds in Critical Care

TRICC - NEJM 1999 -
2011 - Hip Surgery ... 2013 - UGIB TRISS ... - NEJM 2014 - Sepsis ... 2018 - Cardiac Surgery ... /vmoitra) #EBM
A Controlled Trial of Erenumab for Episodic Migraine #EBM #Neuro #Erenumab #Migraine #CGRP #VisualAbstract #NEJM
Episodic Migraine #EBM ... #Neuro #Erenumab ... VisualAbstract #NEJM
Transfusion strategies for acute upper gastrointestinal bleeding - Visual Abstract

Villanueva Cetal. NEJM 2013 PMID 23281973 https://www.ncbi.nlm.nih.gov/pubmed/23281973
NEJM 2013 PMID 23281973 ... by @PulmCrit #EBM
Mortality after Fluid Bolus in African Children with Severe Infection - June 30, 2011 N Engl
Infection - June 30, 2011 ... N Engl J Med 2011 ... NEJMoa1101549 #EBM ... Boluses #Africa #NEJM
The HYPERION Trial - Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm - Visual Abstract

NEJM
Visual Abstract NEJM ... October 2, 2019 ... VisualAbstract #EBM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Decompression Sickness - The physical examination revealed diffuse violaceous skin mottling over his trunk and arms
Clinical #Derm #EM ... #Pneumatosis #CT ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM